Outcome of pulmonary multidrug-resistant tuberculosis

S. Toujani, J. Cherif, N. Mehiri, A. Zouaoui, B. Louzir, M. Beji (Tunis, Tunisia)

Source: Annual Congress 2007 - Medical and surgical treatment of susceptible and resistant tuberculosis

Session: Medical and surgical treatment of susceptible and resistant tuberculosis
Session type: Thematic Poster Session
Number: 2470

Disease area: Respiratory infections

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Toujani, J. Cherif, N. Mehiri, A. Zouaoui, B. Louzir, M. Beji (Tunis, Tunisia). Outcome of pulmonary multidrug-resistant tuberculosis. Eur Respir J 2007; 30: Suppl. 51, 2470

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Treatment results of multidrug-resistant pulmonary tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 11s Year: 2006
Outcome of multidrug resistant pulmonary tuberculosis Source: Annual Congress 2010 - Tuberculosis drug resistance Year: 2010
Surgical approach to multidrug-resistant pulmonary tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 323s Year: 2003
Value of surgery for multidrug-resistant pulmonary tuberculosis in Hungary Source: Eur Respir J 2006; 28: Suppl. 50, 135s Year: 2006
Evaluation of treatment outcomes for multidrug-resistant tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 312s Year: 2001
Management and treatment of multidrug-resistant tuberculosis Source: International Congress 2019 – Tuberculosis: latest advances and challenges in patient management Year: 2019
Pulmonary tuberculosis with primary drug resistant mycobacterium tuberculosis -treatment outcomes Source: Eur Respir J 2004; 24: Suppl. 48, 657s Year: 2004
Predictors of treatment outcome in multidrug-resistant tuberculosis Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis Year: 2011
Diagnosis of COPD in patients with multidrug-resistant tuberculosis Source: International Congress 2018 – COPD around the world Year: 2018
Comorbidome in multidrug-resistant tuberculosis patients Source: Virtual Congress 2020 – Tuberculosis and comorbidities Year: 2020
Epidemiological features of nosocomial tuberculosis in patients with pulmonary tuberculosis in TB hospital Source: International Congress 2018 – Tuberculosis transmission and screening strategies Year: 2018
Management of MDR tuberculosis Source: Short video discussion 2021 Year: 2021
Analysis of loss to follow-up in 4099 multidrug-resistant pulmonary tuberculosis patients Source: Eur Respir J, 54 (1) 1800353; 10.1183/13993003.00353-2018 Year: 2019
Intravenous ozon in MDR pulmonary tuberculosis Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis Year: 2008
The efficiency of surgical treatment for multidrug-resistant pulmonary and pleural tuberculosis Source: International Congress 2016 – Surgical strategy for complex diseases Year: 2016
Effectiveness of thoracoplasty at disseminated drug-resistant fibrous-cavernous pulmonary tuberculosis Source: Annual Congress 2010 - Special treatment options in tuberculosis Year: 2010
Pulmonary tuberculosis Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine Year: 2017
Pulmonary tuberculosis Source: ERS Course 2019 - Summer school of adult respiratory medicine Year: 2019
Pulmonary tuberculosis Source: ERS Course 2018 - Summer school of adult respiratory medicine Year: 2018
Analysis of multidrug-resistant tuberculosis Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1 Year: 2014